Brepocitinib is a potential first-in-class dual, selective inhibitor of TYK2 and JAK1 with IC50s of 17 nM and 23 nM, respectively.
武漢永璨生物科技有限公司
聯(lián)系商家時(shí)請(qǐng)?zhí)峒癱hemicalbook,有助于交易順利完成!
武漢永璨生物